Physician profile
Nicole E Leach
NPI 1417187857
$1,140.75
in general payments reported to CMS, 2019-2025
18 companies · $111 in 2025
The $111 reported for 2025 was more than what a typical Pediatrics (Nurse Practitioner) provider received nationally (typical 2025 total: $93.49).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $452 · 2022: $267 · 2023: $169 · 2024: $142 · 2025: $111.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $422.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $421.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $372.18 | 2021-2025 | |
| Inspire Medical Systems, INC. | $141.94 | 2024 | Inspire |
| Bayer Healthcare Pharmaceuticals INC. | $96.22 | 2025 | |
| Pfizer INC. | $95.61 | 2021-2023 | |
| Novo Nordisk INC | $79.14 | 2021-2022 | |
| Astrazeneca Pharmaceuticals Lp | $57.16 | 2021-2023 | Breztri |
| Eisai INC. | $54.27 | 2021 | |
| Amgen INC. | $51.62 | 2021 | |
| Lilly USA, LLC | $34.98 | 2021 | |
| Janssen Pharmaceuticals, INC | $32.30 | 2021-2023 | Spravato |
| Merck Sharp & Dohme LLC | $29.51 | 2021 | |
| Shield Therapeutics INC | $19.65 | 2023 | Accrufer |
| Novartis Pharmaceuticals Corporation | $14.24 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.06 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $12.41 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $12.24 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $11.74 | 2021 | |
| Antares Pharma, INC. | $11.48 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicole Leach listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.